Cancer Medicines Forum workshop April 5: a way forward for treatment optimizatio…

martin kaiser headshot

The Cancer Medicines Forum (CMF) is hosted by the European Medicines Agency (EMA) in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC).

Read more

Helping to shape Europe’s clinical trials landscape: EHA selected for ACT EU adv…

EHA joins ACT EU advisory board image

Improving the design, efficiency and effectiveness of clinical trials is the objective of the Accelerating Clinical Trials in the European Union (ACT EU) initiative.

Read more

EHA response to the EU’s Pharma Revision

Last week, the European Affairs team finalised EHA's response to the proposed revision of the EU (European Union) Pharmaceutical Legislation.

Read more

Hematology and oncology, pacemakers for EU HTA

EAA HTA panel with M Kaiser

EHA’s Martin Kaiser, right, addressing his fellow panelists. Left to right: Brian Cuffel (Bayer), Caroline Pothet (EMA), Roisin Adams (HTA CG), Bernhard Wörmann (DGHO) and Elisabeth de Vries (ESMO).

Read more

EHA in EU-funded project on voluntary plasma collection capacity in Europe

Plasma

EHA to participate in an EU-funded project on “Strengthening voluntary non-remunerated plasma collection capacity in Europe” (SUPPLY) Context: Plasma shortage  Plasma-derived medicinal products (PDMPs) are used to treat a variety of rare,…

Read more

EHA to the European Commission and HTA leaders: work with medical societies to i…

20220622 HTA Conference speakers

The speakers of the HTA conference hosted by the European Commission.

Read more

New EU In Vitro Diagnostic medical devices Regulation (IVDR) comes into effect

EHA Studio 4

On May 26, 2022, the new EU In Vitro Diagnostic medical devices Regulation (IVDR) came into effect, mandating stricter and more comprehensive certification and testing protocols for in vitro diagnostic…

Read more

EU funding approved for TOLERATE

AdobeStock 68767205

On April 1, the European Commission approved funding for the TOLERATE training network, proposed by a KU Leuven-led consortium including EHA.

Read more

King Baudouin Foundation – Calls with a relevance to hematology

call for proposals cropped2

The King Baudouin Foundation is an actor for change and innovation, serving the public interest and increasing social cohesion.

Read more

EHA endorses the International COVID-19 Blood Cancer Coalition (ICBCC) Statement

HandsWorld

On February 21, the COVID-19 Blood Cancer Coalition (ICBCC), a multi-stakeholder coalition including representatives from the global patient advocacy and clinical community, launched its Joint Patient Impact Statement and Recommendations…

Read more

EU pilot on drug repurposing

AdobeStock 276764998

Drug repurposing (finding new indications for existing authorized medicines) is increasingly prominent in the debate about improving access to medicines.

Read more

EU Calls for Proposal 2022

AdobeStock 353450686

Introduction Spurred by COVID-19 and rising challenges to the financial sustainability of Europe’s health systems, a flurry of new EU policies and programs in health has sprung up since last year.…

Read more

From Plans to Action: European Cancer Summit

MicrosoftTeams image

November 17- 18 marks the first anniversary of EHA’s membership to the European Cancer Organisation (ECO), as well as the event dates for the 2021 European Cancer Summit. The summit brings together the European cancer community: oncology experts, experienced patient advocates, opinion leaders, policymakers, and politicians.

Read more

EU Calls for proposal 2021

call for proposals cropped

Spurred by COVID-19 and rising challenges to the financial sustainability of Europe’s health systems, a flurry of new EU policies and programs in health has sprung up since last year. Some of the most eye-catching initiatives are highly relevant for hematology: the Europe’s Beating Cancer Plan, the Pharmaceutical Strategy and the European Health Data Space.

Read more

Help disseminate IVDR Questionnaire - Share with diagnostic laboratories in your…

AdobeStock 226202110

The new EU Regulation on in vitro diagnostic medical devices (IVDR) will come into full effect per May 26, 2022 and will have substantial consequences for diagnostic laboratories.

Read more